Antibiotics versus placebo for acute bacterial conjunctivitis: Findings from a Cochrane systematic review

Liu, Su-Hsun, Chen, Yu-Yen, Nurmatov, Ulugbek ORCID: https://orcid.org/0000-0002-9557-8635, van Schayck, Onno C.P. and Kuo, Irene C. 2024. Antibiotics versus placebo for acute bacterial conjunctivitis: Findings from a Cochrane systematic review. American Journal of Ophthalmology 257 , pp. 143-153. 10.1016/j.ajo.2023.06.027

Preview	PDF - Accepted Post-Print Version Download (290kB) | Preview
	PDF - Supplemental Material Download (219kB)

Abstract

Purpose To summarize key findings from a Cochrane review of the benefits and safety of antibiotic therapy compared with placebo (or vehicle) for acute bacterial conjunctivitis. Design Systematic review and meta-analysis. Methods We included placebo-controlled randomized controlled trials (RCTs) that compared topical antibiotics with placebo. We followed Cochrane methods for trial selection, data extraction, risk of bias assessment, and evidence synthesis. Results Twenty-one RCTs involving 8805 participants with acute bacterial conjunctivitis were included. Fifteen (71%) RCTs examined fluoroquinolone (FQ) drops, 3 tested macrolides, alone or in combination with steroids, and another 3 compared other non-FQ antibiotics. Intention-to-treat estimates suggested that compared with placebo, antibiotics may increase clinical recovery by 26% (risk ratio [RR]: 1.26; 95% confidence interval [CI]: 1.09-1.46) at the end of therapy (5 RCTs, 1474 participants). Modified intention-to-treat estimates, in which only participants with laboratory-confirmed bacterial conjunctivitis were analyzed, indicated that antibiotics were associated with 53% higher likelihood of microbiological cure as compared with placebo (RR: 1.53; 95% CI: 1.34-1.74; 10 RCTs, 2827 participants). Non-FQs (RR: 4.05; 95% CI: 1.36-12.00), but not FQs (RR: 0.70; 95% CI: 0.54-0.90), were likely to increase treatment-associated ocular complications such as eye pain, discomfort, and allergic reactions; the certainty of level of evidence was very low. Conclusions Moderate level certainty of evidence suggested that antibiotics may increase the likelihood of clinical recovery and microbiological clearance compared with placebo. Very low-level certainty of evidence suggested that antibiotics may be associated with potential harm in patients with acute bacterial conjunctivitis, but the potential risk of bias from study design, inconsistency in outcome measurement, and reporting limit the evidence to very low certainty.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Publisher:	Elsevier
ISSN:	0002-9394
Date of First Compliant Deposit:	26 July 2024
Date of Acceptance:	30 June 2023
Last Modified:	29 Jul 2024 14:45
URI:	https://orca.cardiff.ac.uk/id/eprint/170953

Actions (repository staff only)

Edit Item